Literature DB >> 7479763

Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

B Fineschi1, L S Arneson, M F Naujokas, J Miller.   

Abstract

Invariant chain (Ii) is an intracellular type II transmembrane glycoprotein that is associated with major histocompatibility complex class II molecules during biosynthesis. Ii exists in two alternatively spliced forms, p31 and p41. Both p31 and p41 facilitate folding of class II molecules, promote egress from the endoplasmic reticulum, prevent premature peptide binding, and enhance localization to proteolytic endosomal compartments that are thought to be the sites for Ii degradation, antigen processing, and class II-peptide association. In spite of the dramatic and apparently equivalent effects that p31 and p41 have on class II biosynthesis, the ability of invariant chain to enhance antigen presentation to T cells is mostly restricted to p41. Here we show that degradation of Ii leads to the generation of a 12-kDa amino-terminal fragment that in p41-positive, but not in p31-positive, cells remains associated with class II molecules for an extended time. Interestingly, we find that coexpression of the two isoforms results in a change in the pattern of p31 degradation such that endosomal processing of p31 also leads to extended association of a similar 12-kDa fragment with class II molecules. These data raise the possibility that p41 may have the ability to impart its pattern of proteolytic processing on p31 molecules expressed in the same cells. This would enable a small number of p41 molecules to modify the post-translational transport and/or processing of an entire cohort of class II-Ii complexes in a manner that could account for the unique ability of p41 to enhance antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479763      PMCID: PMC40775          DOI: 10.1073/pnas.92.22.10257

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells.

Authors:  L Karlsson; A Péléraux; R Lindstedt; M Liljedahl; P A Peterson
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

2.  Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and k.

Authors:  N Koch; G J Hämmerling; N Tada; S Kimura; U Hämmerling
Journal:  Eur J Immunol       Date:  1982-11       Impact factor: 5.532

3.  Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.

Authors:  B Arunachalam; C A Lamb; P Cresswell
Journal:  Int Immunol       Date:  1994-03       Impact factor: 4.823

4.  Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.

Authors:  P A Morton; M L Zacheis; K S Giacoletto; J A Manning; B D Schwartz
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

5.  Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin.

Authors:  N Koch; W Lauer; J Habicht; B Dobberstein
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

6.  The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.

Authors:  C C Stebbins; G E Loss; C G Elias; A Chervonsky; A J Sant
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

7.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

8.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.

Authors:  A Sette; S Southwood; J Miller; E Appella
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

9.  Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.

Authors:  G Malcherek; V Gnau; G Jung; H G Rammensee; A Melms
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence.

Authors:  L S Arneson; J Miller
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  9 in total

1.  Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.

Authors:  G Guncar; G Pungercic; I Klemencic; V Turk; D Turk
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.

Authors:  J Deussing; W Roth; P Saftig; C Peters; H L Ploegh; J A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 3.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

4.  Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing.

Authors:  Dalian Zhong; Weiyi Yu; Yuhua Liu; Jing Liu; Jinnian Li
Journal:  Immunogenetics       Date:  2004-11-16       Impact factor: 2.846

5.  Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

Authors:  A J Slavin; J M Soos; O Stuve; J C Patarroyo; H L Weiner; A Fontana; E K Bikoff; S S Zamvil
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.

Authors:  R J Wright; E K Bikoff; B Stockinger
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

7.  Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal.

Authors:  S Ceman; S Wu; T S Jardetzky; A J Sant
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

Review 8.  Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.

Authors:  Jean-Simon Fortin; Maryse Cloutier; Jacques Thibodeau
Journal:  Front Immunol       Date:  2013-12-13       Impact factor: 7.561

Review 9.  Proteolysis and antigen presentation by MHC class II molecules.

Authors:  Paula Wolf Bryant; Ana-Maria Lennon-Duménil; Edda Fiebiger; Cécile Lagaudrière-Gesbert; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.